Applied as monotherapy and as part of a comprehensive treatment of acute and chronic diseases of the musculoskeletal system, such as:
– Diseases accompanied by pain in the back;
– Inflammatory diseases of the musculoskeletal system (arthritis, tendonitis, tenosynovitis);
– Degenerative-dystrophic diseases of joints (arthrosis, gonarthrosis, spondylarthritis)
– Osteochondrosis and osteochondropathy as well as chondroprotectors to prevent lesions of the joints during intense exertion (sport, hard jobs).
– Known hypersensitivity to harpahofitumu or other components of the drug;
– Gastric ulcer and duodenal ulcer, cholelithiasis.
Dosage & Administration
1 tablet 2 times a day while eating at regular intervals, drinking plenty of water.
Term of use – from 4 to 16 weeks.
Recommended refresher courses twice a year (spring and autumn periods of exacerbations of chronic diseases).